CytoVeris

CytoVeris is a medical technology company based in Connecticut, focused on enhancing cancer surgery outcomes through advanced imaging and artificial intelligence. The company develops AI-powered optical imaging solutions that improve intraoperative cancer detection, allowing surgeons to accurately identify and remove cancerous tissue while preserving healthy tissue. The Smart Cancer Imaging Platform from CytoVeris integrates advanced optical imaging technologies and AI algorithms to provide real-time analysis of imaging data. This assists surgeons in detecting residual cancer cells that may be overlooked. Additionally, their OncoLux system combines enhanced visualization with optical photodynamic therapy, enabling surgeons to treat residual cancer during surgery. CytoVeris primarily serves surgical oncologists, hospitals, and cancer treatment centers, aiming to improve surgical precision and patient outcomes. The company is committed to making advanced cancer detection technologies more accessible, ultimately reducing the risk of cancer recurrence and enhancing long-term patient prognosis.

• Employees 8
• Founded 2018
• Total Funding $3725008